Industry News (Therapy)

Human Alpha Interferon Produced from Proprietary Cells

Published in Hepatitis Weekly, April 8th, 1996

Technology Management & Funding, L.P. (TMF), Princeton, New Jersey, announced that AMBA Biosciences, Gaithersburg, Maryland, has used its proprietary human cell lines to produce high levels of human alpha interferon.

AMBA's technology creates an opportunity to produce safe, cost-effective, and highly efficacious alpha interferon, where existing technologies fall short in at least one of these important criteria. Currently alpha interferon is approved for a variety of indications including Hepatitis C and certain cancers.

The product is manufactured through recombinant means or as a "natural" product, consisting of many of the over 20 subtypes of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1996-04-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry